SEARCH

SEARCH BY CITATION

References

  • 1
    Greene MH, Fraumeni JF Jr. The hereditary variant of malignant melanoma. In: ClarkWHJr, MastrangeloMJ, GoldmanLI, eds. Human malignant melanoma. New York: Grune and Stratton, 1979: 13966.
  • 2
    Greene MH, Goldin LR, Clark WH Jr, Lovrien E, Kraemer KH, Tucker MA, et al. Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci USA 1983; 80: 60715.
  • 3
    Risch N, Sherman S. Genetic Analysis Workshop 7 summary of the melanoma workshop. Cytogenet Cell Genet 1992; 59: 14858.
  • 4
    Reimer RR, Clark WH Jr, Greene MH, Ainsworth AM, Fraumeni JF Jr. Precursor lesions in familial melanoma: a new genetic preneoplastic syndrome. JAMA 1978; 239: 7446.
  • 5
    Clark WH Jr, Reimer RR, Greene MH, Ainsworth AA, Mastrangelo MJ. Origin of familial melanomas from heritable melanocytic lesions. Arch Dermatol 1978; 114: 7328.
  • 6
    Greene MH, Reimer RR, Clark WH Jr, Mastrangelo MJ. Precursor lesions in familial melanoma. Semin Oncol 1978; 5: 857.
  • 7
    Elder DE, Greene MH, Bondi EE, Clark WH Jr. Acquired melanocytic nevi and melanoma: the dysplastic nevus syndrome. In: AckermanAB, ed. Pathology of malignant melanoma. New York: Masson, 1981: 185216.
  • 8
    Elder DE, Green MH, Guerry D IV, Kraemer KH, Clark WH Jr. The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982; 4: 45560.
  • 9
    Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Fraser MC, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature [letter]. Lancet 1980; 2: 1024.
  • 10
    Lynch HT, Frichot BC III, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978; 15: 3526.
  • 11
    MacKie RM. Multiple melanoma and atypical melanocytic nevi–evidence of an activated and expanded melanocytic system. Br J Dermatol 1982; 107: 6219.
  • 12
    National Institutes of Health. Consensus development conference: diagnosis and treatment of early melanoma. JAMA 1992; 268: 13149.
  • 13
    Greene M, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanomaprone families with dysplastic nevi. Ann Intern Med 1985; 102: 45865.
  • 14
    Tucker MA, Fraser MC, Goldstein AM, Elder DE, Guerry D, Organic SM. Risk of melanoma and other cancers in melanomaprone families. J Invest Dermatol 1993; 100: 35055.
  • 15
    Halpern AC, Guerry D IV, Elder DE, Clark WH Jr, Synnestvedt M, Norman S, et al. Dysplastic nevi as risk markers of sporadic (non-familial) melanoma: a case-control study. Arch Dermatol 1991; 127: 9959.
  • 16
    Masri GD, Clark WH Jr, Guerry D IV, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990; 22: 10428.
  • 17
    Soyer HP. Ki 67 immunostaining in melanocytic skin tumors: correlation with histologic parameters. J Cutan Pathol 1991; 18: 26472.
  • 18
    Puck TT, Krystosek A. Reverse transformation, genome exposure, and cancer. Adv Cancer Res 1993; 62: 12551.
  • 19
    Pauling L. Biostatistical analysis of mortality data for cohorts of cancer patients. Proc Natl Acad Sci U S A 1989; 86: 34668.
  • 20
    Crijns MB, Vink J, Van Hees CLM, Bergman W, Vermeer BJ. Dysplastic nevi: occurrence in first- and second-degree relatives of patients with ‘sporadic’ dysplastic nevus syndrome. Arch Dermatol 1991; 127: 134651.
  • 21
    Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JAA, Clark J, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. BMJ 1986; 292: 15559.
  • 22
    Nordlund JJ, Kirkwood J, Forget BM, Scheibner A, Albert DM, Lerner E, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45: 185561.
  • 23
    Elder DE, Clark WH Jr, Elenitsas R, Guerry D IV, Halpem AC. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993; 10: 1835.
  • 24
    Holly EA, Kelly JW, Shpall SN, Chiu S-H. Number of melanocytic nevi as a risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 45968.
  • 25
    Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989; 28: 51723.
  • 26
    Augustsson A, Stierner U, Rosdahl I, Suurküla M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol (Stockh) 1991; 71: 51824.
  • 27
    Halpern AC, Guerry D IV, Elder DE, Trock B, Synnestvedt M, Humphreys T. Natural history of dysplastic nevi. J Am Acad Dermatol 1993; 29: 517.
  • 28
    MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in highrisk groups. Lancet 1993; 341: 161820.
  • 29
    Bale SJ, Chakravarti A, Greene MH. Cutaneous malignant melanoma: evidence for autosomal dominant inheritance and pleiotrophy. Am J Hum Genet 1986; 38: 18896.
  • 30
    Bale SJ, Dracopoli NC, Tucker MA, Clark WH Jr, Fraser MC, Stanger BZ, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome lp. N Engl J Med 1989; 320: 136772.
  • 31
    Cannon-Albright LA, Goldgar DE, Wright EC, Turco A, Jost M, Meyer LJ, et al. Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome lp36. Am J Hum Genet 1990; 46: 9128.
  • 32
    Van Haeringen A, Bergman W, Nelan MR, Koon-Meus E, Hendrikse I, Wijnen JT, et al. Exclusion of the dysplastic nevus syndrome locus from the short arm of chromosome 1 by linkage studies in Dutch families. Genomics 1989; 5: 614.
  • 33
    Kefford RF, Salmon J, Shaw HM, Donald JA, McCarthy WH. Hereditary melanoma in Australia: variable association with dysplastic nevi and absence of genetic linkage to chromosome lp. Cancer Genet Cytogenet 1991; 51: 4555.
  • 34
    Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992; 258: 114852.
  • 35
    Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, et al. Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 1993; 53: 93642.
  • 36
    Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, et al. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome Ip, and evidence for genetic heterogeneity. Am J Hum Genet 1993; 52: 53750.
  • 37
    Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 43640.
  • 38
    Smith PJ, Greene MH, Adams D, Paterson MC. Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma. Carcinogenesis 1983; 4: 9116.
  • 39
    Perera MI, Um KI, Greene MH, Waters HL, Bredberg A, Kraemer KH. Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res 1986; 46: 10059.
  • 40
    Jung EG, Bohnert E, Boonen H. Dysplastic nevus syndrome: ultraviolet hypermutability confirmed in vitro by elevated sister chromatid exchanges. Dermatologica 1986; 173: 297300.
  • 41
    Roth M, Boyle JM, Muller H. Thymine dimer repair in fibroblasts of patients with dysplastic naevus syndrome (DNS). Experientia 1988; 44: 16971.
  • 42
    Lu GH, Hayward NK, Stanley WS. Spontaneous and 4-nitroquinoline 1-oxide-induced G2 chromosome aberrations in lymphoblasts from familial melanoma patients. Cancer Genet Cytogenet 1989; 39: 23343.
  • 43
    Caporaso N, Greene MH, Tsai S, Pickle LW, Mulvihill JJ. Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet 1987; 24: 299314.
  • 44
    Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 1991; 83: 172633.
  • 45
    MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989; 2: 48790.
  • 46
    Halpern AC, Guerry D, Elder DE, Trock B, Synnestvedt M. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993; 100: 3465.